MAZE THERAPEUTICS INC (MAZE) Stock Analyst Earnings Estimates
NASDAQ:MAZE - Nasdaq - US5787841007 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 167.5M | 2.55M -98.48% | -100.00% | 2.55M | |||
| EBITDA YoY % growth | -107.206M | -94.462M 11.89% | 60.883M 164.45% | -154.02M -352.98% | -161.16M -4.64% | -189.72M -17.72% | |
| EBIT YoY % growth | -111.026M | -98.551M 11.24% | 57.586M 158.43% | -147.666M -356.43% | -166.246M -12.58% | -186.998M -12.48% | |
| Operating Margin | N/A | N/A | 34.38% | -5,790.84% | N/A | -7,333.27% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.73 84.68% | -3.58 3.92% | -3.37 5.95% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.93 | -0.90 95.10% | -0.90 21.42% |
| Revenue Q2Q % growth | -100.00% | ||
| EBITDA Q2Q % growth | -39.78M -83.85% | -40.8M -54.38% | N/A |
| EBIT Q2Q % growth | -38.051M -57.05% | -38.989M -31.16% | -39.933M -32.09% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.77 | -0.87 | 0.10 | 11.81% |
| Q1 2025 Q2Q % growth | -1.15 | -0.77 | -0.38 | -49.66% |
| Q4 2024 Q2Q % growth | -18.32 | 0.46 | -18.78 | -4,091.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 2.125M | -2.125M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -35.46% |
| Revenue | N/A | N/A | 0% | -20.01% |